ImmunityBio Advances First-Line BCG Naive NMIBC Program with Enrollment Exceeding Expectations and Positive Interim Analysis for ANKTIVA® Plus BCG

ImmunityBio, Inc. (NASDAQ: IBRX) today announced an update on the status of enrollment in its randomized registrational trial ...

ImmunityBio's Promising Advances in BCG Naïve NMIBC Treatment with ANKTIVA Plus BCG

Enrollment Progress in QUILT-2.005 The QUILT-2.005 trial aims to evaluate the efficacy of ANKTIVA® in conjunction with BCG in patients who have not previously received BCG treatment. As of January ...
Yahoo Finance

BCG Vaccines Market Analysis 2020-2024 and Forecast 2025-2030 - Asia-Pacific Estimated to Reach 40% Revenue Share by 2029, Owing to High TB Rates

Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "BCG Vaccine Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology" report has been added to ...
Bangkok Post

NGOs analyse BCG model

Non-profit groups are urging the government to implement the Bio-Circular-Green (BCG) Economy to benefit the grassroots of society after the model was introduced during the Asia-Pacific Economic ...
PharmiWeb

BCG Vaccine Market: Comprehensive Analysis of Growth Trajectory and Future Prospects

BCG Vaccine Market: Comprehensive Analysis of Growth Trajectory and Future Prospects Key Takeaways The global BCG vaccine market is experiencing robust growth, valued at USD 5.5 billion in 2024 and ...